nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—PRKDC—midbrain—Gilles de la Tourette syndrome	0.0369	0.047	CbGeAlD
Caffeine—ATM—nervous system—Gilles de la Tourette syndrome	0.032	0.0408	CbGeAlD
Caffeine—ATM—central nervous system—Gilles de la Tourette syndrome	0.0309	0.0393	CbGeAlD
Caffeine—PIK3CB—midbrain—Gilles de la Tourette syndrome	0.0302	0.0384	CbGeAlD
Caffeine—RYR1—midbrain—Gilles de la Tourette syndrome	0.0298	0.038	CbGeAlD
Caffeine—PIK3CA—midbrain—Gilles de la Tourette syndrome	0.0298	0.038	CbGeAlD
Caffeine—PIK3CD—nervous system—Gilles de la Tourette syndrome	0.0284	0.0362	CbGeAlD
Caffeine—PIK3CD—central nervous system—Gilles de la Tourette syndrome	0.0274	0.0349	CbGeAlD
Caffeine—PIK3CB—nervous system—Gilles de la Tourette syndrome	0.0248	0.0316	CbGeAlD
Caffeine—RYR1—nervous system—Gilles de la Tourette syndrome	0.0245	0.0313	CbGeAlD
Caffeine—PIK3CA—nervous system—Gilles de la Tourette syndrome	0.0245	0.0313	CbGeAlD
Caffeine—ATM—brain—Gilles de la Tourette syndrome	0.0245	0.0312	CbGeAlD
Caffeine—PIK3CB—central nervous system—Gilles de la Tourette syndrome	0.0239	0.0304	CbGeAlD
Caffeine—RYR1—central nervous system—Gilles de la Tourette syndrome	0.0236	0.0301	CbGeAlD
Caffeine—PIK3CA—central nervous system—Gilles de la Tourette syndrome	0.0236	0.0301	CbGeAlD
Caffeine—PRKDC—brain—Gilles de la Tourette syndrome	0.0232	0.0295	CbGeAlD
Caffeine—PIK3CD—brain—Gilles de la Tourette syndrome	0.0217	0.0277	CbGeAlD
Caffeine—PIK3CB—brain—Gilles de la Tourette syndrome	0.0189	0.0241	CbGeAlD
Caffeine—RYR1—brain—Gilles de la Tourette syndrome	0.0188	0.0239	CbGeAlD
Caffeine—PIK3CA—brain—Gilles de la Tourette syndrome	0.0188	0.0239	CbGeAlD
Caffeine—ADORA2B—nervous system—Gilles de la Tourette syndrome	0.0181	0.023	CbGeAlD
Caffeine—ADORA2B—central nervous system—Gilles de la Tourette syndrome	0.0174	0.0221	CbGeAlD
Caffeine—ADORA1—midbrain—Gilles de la Tourette syndrome	0.0158	0.0201	CbGeAlD
Caffeine—ADORA2A—nervous system—Gilles de la Tourette syndrome	0.015	0.0191	CbGeAlD
Caffeine—ADORA2A—central nervous system—Gilles de la Tourette syndrome	0.0145	0.0184	CbGeAlD
Caffeine—ADORA2B—brain—Gilles de la Tourette syndrome	0.0138	0.0176	CbGeAlD
Caffeine—ADORA1—nervous system—Gilles de la Tourette syndrome	0.013	0.0165	CbGeAlD
Caffeine—ADORA2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0126	0.0583	CbGpPWpGaD
Caffeine—ADORA1—central nervous system—Gilles de la Tourette syndrome	0.0125	0.0159	CbGeAlD
Caffeine—PDE4B—midbrain—Gilles de la Tourette syndrome	0.0117	0.0149	CbGeAlD
Caffeine—ADORA2A—brain—Gilles de la Tourette syndrome	0.0115	0.0146	CbGeAlD
Caffeine—ADORA1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0107	0.0496	CbGpPWpGaD
Caffeine—ADORA1—brain—Gilles de la Tourette syndrome	0.00991	0.0126	CbGeAlD
Caffeine—PDE4B—nervous system—Gilles de la Tourette syndrome	0.00959	0.0122	CbGeAlD
Caffeine—PDE4B—central nervous system—Gilles de la Tourette syndrome	0.00924	0.0118	CbGeAlD
Caffeine—ADORA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00824	0.0383	CbGpPWpGaD
Caffeine—CYP1B1—nervous system—Gilles de la Tourette syndrome	0.00822	0.0105	CbGeAlD
Caffeine—CYP1B1—central nervous system—Gilles de la Tourette syndrome	0.00792	0.0101	CbGeAlD
Caffeine—PDE4B—brain—Gilles de la Tourette syndrome	0.00733	0.00934	CbGeAlD
Caffeine—ADORA2A—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00663	0.0308	CbGpPWpGaD
Caffeine—CYP1B1—brain—Gilles de la Tourette syndrome	0.00628	0.00801	CbGeAlD
Caffeine—CYP1A1—nervous system—Gilles de la Tourette syndrome	0.00581	0.00741	CbGeAlD
Caffeine—CYP1A1—central nervous system—Gilles de la Tourette syndrome	0.0056	0.00713	CbGeAlD
Caffeine—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.0053	0.00675	CbGeAlD
Caffeine—PIK3CB—Signaling events mediated by TCPTP—MET—Gilles de la Tourette syndrome	0.00523	0.0243	CbGpPWpGaD
Caffeine—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.0051	0.0065	CbGeAlD
Caffeine—CYP2C8—brain—Gilles de la Tourette syndrome	0.00481	0.00613	CbGeAlD
Caffeine—PIK3CA—Signaling of Hepatocyte Growth Factor Receptor—MET—Gilles de la Tourette syndrome	0.0047	0.0218	CbGpPWpGaD
Caffeine—PRKDC—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00456	0.0212	CbGpPWpGaD
Caffeine—CYP1A1—brain—Gilles de la Tourette syndrome	0.00444	0.00566	CbGeAlD
Caffeine—PRKDC—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00443	0.0206	CbGpPWpGaD
Caffeine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00426	0.00543	CbGeAlD
Caffeine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.0042	0.00535	CbGeAlD
Caffeine—PRKDC—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00413	0.0192	CbGpPWpGaD
Caffeine—PIK3CA—Signaling events mediated by TCPTP—MET—Gilles de la Tourette syndrome	0.00412	0.0192	CbGpPWpGaD
Caffeine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00411	0.00523	CbGeAlD
Caffeine—CYP2E1—brain—Gilles de la Tourette syndrome	0.00405	0.00516	CbGeAlD
Caffeine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00404	0.00515	CbGeAlD
Caffeine—PIK3CA—a6b1 and a6b4 Integrin signaling—MET—Gilles de la Tourette syndrome	0.00375	0.0174	CbGpPWpGaD
Caffeine—ATM—Signaling Pathways in Glioblastoma—MET—Gilles de la Tourette syndrome	0.00375	0.0174	CbGpPWpGaD
Caffeine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00367	0.00468	CbGeAlD
Caffeine—PIK3CD—Signaling Pathways in Glioblastoma—MET—Gilles de la Tourette syndrome	0.00338	0.0157	CbGpPWpGaD
Caffeine—PIK3CA—FGF signaling pathway—MET—Gilles de la Tourette syndrome	0.00324	0.0151	CbGpPWpGaD
Caffeine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00321	0.00409	CbGeAlD
Caffeine—ADORA2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00312	0.0145	CbGpPWpGaD
Caffeine—ADORA2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00303	0.0141	CbGpPWpGaD
Caffeine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00302	0.00385	CbGeAlD
Caffeine—PIK3CB—Signaling Pathways in Glioblastoma—MET—Gilles de la Tourette syndrome	0.00295	0.0137	CbGpPWpGaD
Caffeine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00291	0.0037	CbGeAlD
Caffeine—PIK3CA—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MET—Gilles de la Tourette syndrome	0.00237	0.011	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways in Glioblastoma—MET—Gilles de la Tourette syndrome	0.00232	0.0108	CbGpPWpGaD
Caffeine—ABCB1—brain—Gilles de la Tourette syndrome	0.00231	0.00294	CbGeAlD
Caffeine—ADORA1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00215	0.00997	CbGpPWpGaD
Caffeine—ADORA1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00208	0.00968	CbGpPWpGaD
Caffeine—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00207	0.0096	CbGpPWpGaD
Caffeine—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00201	0.00932	CbGpPWpGaD
Caffeine—ADORA2A—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00198	0.00919	CbGpPWpGaD
Caffeine—RYR1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00195	0.00905	CbGpPWpGaD
Caffeine—ADORA1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00194	0.00901	CbGpPWpGaD
Caffeine—ADORA1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00189	0.0088	CbGpPWpGaD
Caffeine—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00187	0.00868	CbGpPWpGaD
Caffeine—ADORA1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00184	0.00854	CbGpPWpGaD
Caffeine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00177	0.00823	CbGpPWpGaD
Caffeine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00176	0.00816	CbGpPWpGaD
Caffeine—PIK3CD—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.00173	0.00802	CbGpPWpGaD
Caffeine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00172	0.00798	CbGpPWpGaD
Caffeine—ADORA1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00171	0.00795	CbGpPWpGaD
Caffeine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00171	0.00792	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00166	0.0077	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00161	0.00747	CbGpPWpGaD
Caffeine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0016	0.00744	CbGpPWpGaD
Caffeine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00159	0.00738	CbGpPWpGaD
Caffeine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00151	0.00699	CbGpPWpGaD
Caffeine—PIK3CB—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.0015	0.00699	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.0015	0.00696	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—HDC—Gilles de la Tourette syndrome	0.0015	0.00695	CbGpPWpGaD
Caffeine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00146	0.00679	CbGpPWpGaD
Caffeine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00136	0.00632	CbGpPWpGaD
Caffeine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00136	0.0063	CbGpPWpGaD
Caffeine—ADORA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00135	0.00626	CbGpPWpGaD
Caffeine—PIK3CA—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00135	0.00626	CbGpPWpGaD
Caffeine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00132	0.00612	CbGpPWpGaD
Caffeine—ADORA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00131	0.00608	CbGpPWpGaD
Caffeine—ADORA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00131	0.00608	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—HDC—Gilles de la Tourette syndrome	0.0013	0.00606	CbGpPWpGaD
Caffeine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00123	0.0057	CbGpPWpGaD
Caffeine—ADORA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00122	0.00566	CbGpPWpGaD
Caffeine—PIK3CA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0012	0.0056	CbGpPWpGaD
Caffeine—PIK3CA—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.00119	0.00551	CbGpPWpGaD
Caffeine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00116	0.0054	CbGpPWpGaD
Caffeine—ADORA1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00115	0.00533	CbGpPWpGaD
Caffeine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00113	0.00524	CbGpPWpGaD
Caffeine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00112	0.00521	CbGpPWpGaD
Caffeine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00517	CbGpPWpGaD
Caffeine—ADORA1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00111	0.00517	CbGpPWpGaD
Caffeine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00105	0.00488	CbGpPWpGaD
Caffeine—ADORA1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00104	0.00482	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—HDC—Gilles de la Tourette syndrome	0.00103	0.00478	CbGpPWpGaD
Caffeine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000954	0.00443	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000885	0.00411	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000882	0.0041	CbGpPWpGaD
Caffeine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000859	0.00399	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000859	0.00399	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000857	0.00398	CbGpPWpGaD
Caffeine—ADORA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000854	0.00397	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000801	0.00372	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000801	0.00372	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000798	0.00371	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000778	0.00361	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000769	0.00357	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000762	0.00354	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000747	0.00347	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00074	0.00344	CbGpPWpGaD
Caffeine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000736	0.00342	CbGpPWpGaD
Caffeine—ADORA1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000726	0.00337	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000725	0.00337	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000698	0.00324	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000696	0.00323	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000692	0.00321	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000689	0.0032	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000678	0.00315	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000672	0.00312	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000648	0.00301	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00064	0.00297	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000632	0.00293	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000629	0.00292	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000626	0.00291	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000622	0.00289	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000606	0.00282	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—HDC—Gilles de la Tourette syndrome	0.0006	0.00279	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000588	0.00273	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000588	0.00273	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000586	0.00272	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000581	0.0027	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000579	0.00269	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000571	0.00265	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000564	0.00262	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000561	0.0026	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000559	0.0026	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00055	0.00256	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000548	0.00255	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	0.000541	0.00251	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000534	0.00248	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000532	0.00247	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000526	0.00244	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000508	0.00236	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0005	0.00232	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000498	0.00231	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000487	0.00226	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000486	0.00226	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000483	0.00224	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000473	0.0022	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00046	0.00213	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000454	0.00211	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000452	0.0021	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000442	0.00205	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000441	0.00205	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000438	0.00204	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000428	0.00199	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000413	0.00192	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000411	0.00191	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00041	0.00191	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000409	0.0019	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000406	0.00188	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000401	0.00186	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000397	0.00184	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000392	0.00182	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	0.000391	0.00182	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000384	0.00178	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000373	0.00173	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000373	0.00173	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00037	0.00172	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000369	0.00172	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000368	0.00171	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000349	0.00162	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000348	0.00161	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000343	0.0016	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	0.000339	0.00157	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000337	0.00157	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000333	0.00155	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000325	0.00151	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000317	0.00147	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000316	0.00147	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000314	0.00146	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000311	0.00144	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.0003	0.00139	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000295	0.00137	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000294	0.00137	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000288	0.00134	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000278	0.00129	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.000276	0.00128	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000268	0.00125	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000261	0.00121	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000261	0.00121	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000259	0.0012	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000243	0.00113	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000236	0.00109	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00022	0.00102	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000219	0.00102	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000218	0.00101	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000206	0.000957	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000182	0.000845	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00017	0.00079	CbGpPWpGaD
